Bone Biologics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 13 Sep 23 | BuyUS$5,120 | Deina Walsh | Individual | 1,000 | US$5.12 | |
| 11 Sep 23 | BuyUS$6,530 | Jeffrey Frelick | Individual | 1,187.5 | US$5.50 | |
| 06 Sep 23 | BuyUS$4,967 | Deina Walsh | Individual | 875 | US$5.68 | |
| 31 Aug 23 | BuyUS$5,020 | Jeffrey Frelick | Individual | 950 | US$5.28 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 9,721 | 1.11% |
| Institutions | 65,667 | 7.47% |
| Private Companies | 78,005 | 8.87% |
| General Public | 725,783 | 82.6% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1163.3%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 39,733 | US$75.5k | 0% | no data | |||
| 36,914 | US$70.1k | 1,020% | no data | |||
| 34,180 | US$64.9k | 34.7% | 0.22% | |||
| 16,942 | US$32.2k | 132% | 100.0% | |||
| 9,877 | US$18.8k | 0% | 0.11% | |||
| 5,695 | US$10.8k | -68.1% | no data | |||
| 2,663 | US$5.1k | 0.08% | no data | |||
| 2,151 | US$4.1k | 0% | no data | |||
| 2,001 | US$3.8k | 0% | no data | |||
| 1,875 | US$3.6k | 0% | no data | |||
| 1,225 | US$2.3k | 46.7% | no data | |||
| 133 | US$252.7 | 0.76% | no data | |||
| 4 | US$7.5 | 33.3% | no data |